Mastering Current Management of CLL

Learn how hematology-oncology pharmacists can optimize outcomes for patients with CLL with an expert commentary plus on-demand Webcast and downloadable slides from a live CCO Webinar.

Share

Program Content

Activities

CLL/SLL Tx With BTKis
Overview of CLL/SLL Treatment Landscape: Mastering Treatments and Special Considerations in CLL/SLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 07, 2021

Expires: May 06, 2022

Pharm Expert CLL Mngmt
Effective Management of CLL/SLL by Pharmacists: Supportive Care Challenges and Resources for Patients
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 07, 2021

Expires: May 06, 2022

Mastering CLL Management
ExpressPoints
Mastering Current Management of CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 12, 2021

Expires: May 11, 2022

Activities

BTKi for CLL: Pharmacist’s View
Optimizing Management of CLL With BTK Inhibitors: A Pharmacist’s Perspective
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 29, 2021

Expires: April 28, 2022

FAQs: BTKi for CLL
Answers to Frequently Asked Questions on Optimizing CLL Management With BTK Inhibitors
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 21, 2021

Expires: May 20, 2022

Activities

Mastering CLL Management
Mastering Current Management of CLL
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: May 24, 2021

Expires: May 23, 2022

Faculty

cover img faculity

Emily Bucholtz, RPh

Pharmacist
Willamette Valley Cancer Institution
Eugene, Oregon

cover img faculity

Jeffrey P. DONOTUSESharman, MD

Medical Oncologist
Willamette Valley Cancer Institute and Research Center
Springfield, Oregon

cover img faculity

Jeff DONOTUSESharman, MD

Medical Director of Hematology Research
Willamette Valley Cancer Institute
US Oncology
Eugene, Oregon

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie

AstraZeneca

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Pharmacyclics AbbVie